Skip to main content

Advertisement

SpringerLink
Log in

Temporal Profile of Diabetic Nephropathy Pathologic Changes

  • Microvascular Complications-Nephropathy (B Roshan, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Diabetic nephropathy, by far, is the most common cause of end stage renal disease in the US and many other countries. In type 1 diabetes, the natural history of diabetic nephropathy is tightly linked to evolution of classic lesions of the disease, namely glomerular basement membrane thickening, increased mesangial matrix, and reduced glomerular filtration surface density. These lesions progress in parallel and correlate with increased albumin excretion rate and reduced glomerular filtration rate across a wide range of renal function. In fact, the vast majority of the variances of albumin excretion and glomerular filtration rates can be explained by these glomerular lesions alone in type 1 diabetic patients. Although, classic lesions of diabetic nephropathy, indistinguishable from those of type 1 diabetes, also occur in type 2 diabetes, renal lesions are more heterogeneous in type 2 diabetic patients with some patients developing more advanced vascular or chronic tubulointerstitial lesions than diabetic glomerulopathy. More research biopsy longitudinal studies, especially in type 2 diabetic patients, are needed to better understand various pathways of renal injury in diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. USRDS, U S Renal Data System, USRDS 2012 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. 2012.

  2. Krolewski AS, Bonventre JV. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol. 2012;32:407–14.

    Article  PubMed  Google Scholar 

  3. Osterby R. Kidney structural abnormalities in early diabetes. Adv Metab Disord. 1973;2 Suppl 2:323–40.

    PubMed  Google Scholar 

  4. • Caramori ML et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes. 2002;51:506–13. This study describes structural-functional relationships of diabetic nephropathy in a wide range of renal function in type 1 diabetic patients in a cross-sectional design.

    Article  PubMed  CAS  Google Scholar 

  5. Steffes MW et al. Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus. N Engl J Med. 1985;312:1282–7.

    Article  PubMed  CAS  Google Scholar 

  6. Osterby R, Nyberg G. New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabetes Complicat. 1987;1:122–7.

    Article  CAS  Google Scholar 

  7. Mauer SM et al. Structural-functional relationships in diabetic nephropathy. J Clin Invest. 1984;74:1143–55.

    Article  PubMed  CAS  Google Scholar 

  8. Steffes MW et al. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes. 1992;41:679–84.

    Article  PubMed  CAS  Google Scholar 

  9. • Steinke JM et al. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes. 2005;54:2164–71. This study describes early glomerular structural changes in type 1 diabetic patients in a large cohort and examines which parameters at baseline predict progression to microalbuminuria at 5 years follow up.

    Article  PubMed  CAS  Google Scholar 

  10. Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes. 2002;51:1580–7.

    Article  PubMed  CAS  Google Scholar 

  11. Saito Y et al. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions. Kidney Int. 1988;34:389–96.

    Article  PubMed  CAS  Google Scholar 

  12. Moriya T et al. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes. Kidney Int. 2012;81:486–93.

    Article  PubMed  CAS  Google Scholar 

  13. Osterby R et al. Glomerular volume and the glomerular vascular pole area in patients with insulin-dependent diabetes mellitus. Virchows Arch. 1997;431:351–7.

    Article  PubMed  CAS  Google Scholar 

  14. Bilous RW et al. Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes. 1989;38:1142–7.

    Article  PubMed  CAS  Google Scholar 

  15. Bendtsen TF, Nyengaard JR. The number of glomeruli in type 1 (insulin-dependent) and type 2 (noninsulin-dependent) diabetic patients. Diabetologia. 1992;35:844–50.

    Article  PubMed  CAS  Google Scholar 

  16. White KE et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes. 2002;51:3083–9.

    Article  PubMed  CAS  Google Scholar 

  17. Patari A et al. Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes. 2003;52:2969–74.

    Article  PubMed  Google Scholar 

  18. Perrin NE et al. The course of diabetic glomerulopathy in patients with type I diabetes: a 6-year follow-up with serial biopsies. Kidney Int. 2006;69:699–705.

    Article  PubMed  CAS  Google Scholar 

  19. Toyoda M et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes. 2007;56:2155–60.

    Article  PubMed  CAS  Google Scholar 

  20. Nakamura T et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant. 2000;15:1379–83.

    Article  PubMed  CAS  Google Scholar 

  21. Steffes MW et al. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001;59:2104–13.

    PubMed  CAS  Google Scholar 

  22. Pagtalunan ME et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–8.

    Article  PubMed  CAS  Google Scholar 

  23. Dalla Vestra M et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52:1031–5.

    Article  PubMed  CAS  Google Scholar 

  24. Weil EJ et al. Podocyte detachment in type 2 diabetic nephropathy. Am J Nephrol. 2011;33 Suppl 1:21–4.

    Article  PubMed  Google Scholar 

  25. Weil EJ et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int. 2012;82:1010–7.

    Article  PubMed  Google Scholar 

  26. •• Najafian B et al. Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol. 2006;17(4 Suppl 2):S53–60. This study describes glomerulotubular junctionabnormalities in diabetic nephropathy in type 1 diabetes. In addition, it suggests through structural-functional relationship models that the vast majority of AER and GFR variance in type 1 diabetic patients can be explained by glomerular lesions alone.

    Article  PubMed  Google Scholar 

  27. Najafian B et al. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol. 2003;14:908–17.

    Article  PubMed  Google Scholar 

  28. Friedrich C et al. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Ren Physiol. 2006;291:F856–65.

    Article  CAS  Google Scholar 

  29. Brito PL et al. Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int. 1998;53:754–61.

    Article  PubMed  CAS  Google Scholar 

  30. Thomsen OF et al. Renal changes in long-term type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material. Diabetologia. 1984;26:361–5.

    Article  PubMed  CAS  Google Scholar 

  31. Bohle A et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract. 1991;187:251–9.

    Article  PubMed  CAS  Google Scholar 

  32. Katz A et al. An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int. 2002;61:2058–66.

    Article  PubMed  Google Scholar 

  33. Mauer SM et al. Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med. 1976;295:916–20.

    Article  PubMed  CAS  Google Scholar 

  34. Harris RD et al. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int. 1991;40:107–14.

    Article  PubMed  CAS  Google Scholar 

  35. Osterby R et al. Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant. 1999;14:348–52.

    Article  PubMed  CAS  Google Scholar 

  36. Horlyck A, Gundersen HJ, Osterby R. The cortical distribution pattern of diabetic glomerulopathy. Diabetologia. 1986;29:146–50.

    Article  PubMed  CAS  Google Scholar 

  37. Perkins BA et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007;18:1353–61.

    Article  PubMed  CAS  Google Scholar 

  38. Hayashi H et al. An electron microscopic study of glomeruli in Japanese patients with noninsulin dependent diabetes mellitus. Kidney Int. 1992;41:749–57.

    Article  PubMed  CAS  Google Scholar 

  39. Lemley KV. Diabetes and chronic kidney disease: lessons from the Pima Indians. Pediatr Nephrol. 2008;23:1933–40.

    Article  PubMed  Google Scholar 

  40. Lemley KV et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int. 2000;58:1228–37.

    Article  PubMed  CAS  Google Scholar 

  41. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27:195–207.

    Article  PubMed  Google Scholar 

  42. Mazzucco G et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis. 2002;39:713–20.

    Article  PubMed  Google Scholar 

  43. Fioretto P et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia. 1996;39:1569–76.

    Article  PubMed  CAS  Google Scholar 

  44. Tervaert TW et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556–63.

    Article  PubMed  Google Scholar 

  45. Fioretto P, Mauer M. Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol. 2010;6:508–10.

    Article  PubMed  Google Scholar 

  46. Okada T et al. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Nephrology. 2012;17:68–75.

    Article  PubMed  CAS  Google Scholar 

  47. Oh SW et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract. 2012;97:418–24.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was in part supported by grants from the National Institutes of Health (NIH) (DK13083) and 2P01DK013083 and National Center for Research Resources (MO1-KK00400). Behzad Najafian has received a subaward of N001447101 from NIH.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Cecilia Ponchiardi declares that she has no conflict of interest.

Michael Mauer declares that he has no conflict of interest.

Behzad Najafian is a PI and co-PI of grants supported by the Genzyme and Roche.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Pathology, University of Washington, 1959 NE Pacific St, Seattle, WA, Box 356100, 98195, USA

    Cecilia Ponchiardi & Behzad Najafian

  2. Departments of Pediatrics and Medicine, University of Minnesota, Minneapolis, MN, USA

    Michael Mauer

Authors
  1. Cecilia Ponchiardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Mauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Behzad Najafian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Behzad Najafian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ponchiardi, C., Mauer, M. & Najafian, B. Temporal Profile of Diabetic Nephropathy Pathologic Changes. Curr Diab Rep 13, 592–599 (2013). https://doi.org/10.1007/s11892-013-0395-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-013-0395-7

Keywords

Search

Navigation